Haemonetics (HAE) Tops Q2 EPS by 11c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $84.13 +0.61%
EPS Growth %: +15.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: +15.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.62, $0.11 better than the analyst estimate of $0.51. Revenue for the quarter came in at $209 million versus the consensus estimate of $207.65 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SunPower (SPWR) determined prior financial statements should no longer be relied upon
- Pioneer Power (PPSI) Receives Nasdaq Non-compliance Notice
- Fiserv (FI) Tops Q1 EPS by 9c; Boosts outlook
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
